title: Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations.
abstract: OBJECTIVE
  In September 2012 an interactive course on the "Interface Management of Pharmacotherapy" was organized by the Stockholm Drug and Therapeutics Committee in cooperation with Department of Clinical Pharmacology at Karolinska Institutet and at Karolinska University Hospital in Stockholm, Sweden, in collaboration with the WHO. The basis for the course was the "Stockholm model" for the rational use of medicines but also contained presentations about successful models in interface management of pharmacotherapy in other European countries.
  
  
  METHODS
  The "Stockholm model" consists of 8 components: 1) Independent Drug and Therapeutics Committee with key role for respected drug experts with policy for "interest of conflicts", 2) The "Wise List", recommendations of medicines jointly for primary and hospital care, 3) Communication strategy with continuous medical education, 4) Systematic introduction of new expensive medicines, 5) E-pharmacological support at "point of care", 6) Methods and tools for follow-up of medicines use, 7) Medicines policy strategy and 8) Operative resources.
  
  
  RESULTS
  The course highlighted the importance of efficient and targeted communication of drug recommendations building on trust among prescribers and patients for the guidelines to achieve high adherence. Trust is achieved by independent Drug and Therapeutics Committees with a key role for respected experts and a strict policy for "conflicts of interest". Representations of GPs are also crucial for successful implementation, being the link between evidence based medicine and practice.
  
  
  CONCLUSIONS
  The successful models in Scotland and in Stockholm as well as the ongoing work in Catalonia were considered as examples of multifaceted approaches to improve the quality of medicine use across primary and hospital care.
authors: Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden. linda.bjorkhem-bergman@ki.se
authors: Linda
authors: L
authors: Björkhem-Bergman
authors: Eva
authors: E
authors: Andersén-Karlsson
authors: Richard
authors: R
authors: Laing
authors: Eduardo
authors: E
authors: Diogene
authors: Oyvind
authors: O
authors: Melien
authors: Malena
authors: M
authors: Jirlow
authors: Rickard E
authors: RE
authors: Malmström
authors: Sabine
authors: S
authors: Vogler
authors: Brian
authors: B
authors: Godman
authors: Lars L
authors: LL
authors: Gustafsson
mesh_terms: D004358:Drug Therapy; D005060:Europe; D005569:Formularies as Topic; D006785:Hospitals, University; D006801:Humans; D008962:Models, Theoretical; D010606:Pharmacy and Therapeutics Committee; D011320:Primary Health Care
references: Appl Health Econ Health Policy. 2013 Feb;11(1):79-82
references: 23322546
references: J Epidemiol Community Health. 2011 May;65(5):387-8
references: 21172797
references: Afr Health. 1991 Nov;14(1):32-3
references: 12343453
references: Pharm World Sci. 2005 Apr;27(2):116-20
references: 15999922
references: Lancet. 2003 May 17;361(9370):1723-9
references: 12767751
references: Lakartidningen. 2009 Nov 4-12;106(45):3019-20
references: 19998831
references: Eur J Clin Pharmacol. 2009 Jun;65(6):627-33
references: 19205683
references: Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):439-41
references: 22971029
references: Scott Med J. 2007 Aug;52(3):20-6
references: 17874711
references: Expert Rev Pharmacoecon Outcomes Res. 2009 Dec;9(6):569-81
references: 19941434
references: Lancet. 2003 Oct 11;362(9391):1225-30
references: 14568747
references: Basic Clin Pharmacol Toxicol. 2011 Apr;108(4):224-33
references: 21414143
references: Am J Health Syst Pharm. 2010 Aug 15;67(16):1378-82
references: 20689130
references: Int J Med Inform. 2007 Jul;76(7):497-506
references: 16621683
references: Appl Health Econ Health Policy. 2012 Jul 1;10(4):217-25
references: 22676213